Non-traditional trial designs can help improve the feasibility of biomarker-based screening by accelerating patient recruitment and contributing to cost savings in clinical development.

Nearly 700,000 women will be recruited into an NHS trial of artificial intelligence (AI) tools for breast cancer screening in an attempt to spot the disease earlier and save lives. The EDITH ...

NIH Revolts: Scientists Decry Budget Cuts, RFK Jr. Political Interference, Warn Of Long-Term Public Health Damage RFK Jr. Champions 'Medical Freedom' While Curtailing Access, Say Public Health Experts ...